Biomarin Pharmaceutical (BMRN) Change in Intangibles (2017 - 2019)

Biomarin Pharmaceutical (BMRN) has 3 years of Change in Intangibles data on file, last reported at $10.0 million in Q4 2019.

• Quarterly Change in Intangibles fell 66.67% year-over-year to $10.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $55.0 million (down 64.52% YoY) and the FY2019 annual result came in at $25.0 million, down 50.0% from the prior year.
• Change in Intangibles declined to $10.0 million in Q4 2019, from $15.0 million in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of $125.0 million in Q4 2017 to a low of $10.0 million in Q4 2019.
• A 3-year average of $45.0 million and a median of $22.5 million in 2018 frame the typical range for Change in Intangibles.
• Annual changes were most pronounced in 2018 — Change in Intangibles plunged 76.0% — and 2019, when it slumped 66.67%.
• Tracing BMRN's Change in Intangibles over 3 years: stood at $125.0 million in 2017, then sank by 76.0% to $30.0 million in 2018, then slumped by 66.67% to $10.0 million in 2019.
• The last three Change in Intangibles figures came in at $10.0 million (Q4 2019), $15.0 million (Q3 2019), and $30.0 million (Q4 2018), per Business Quant data.